在严重的米特拉年和门化的情况下,通过透气管辅助的利索特里普西替换米特拉
Puvi Seshiah1,2, Santiago Garcia1,2, Joseph Choo1,2
1The Christ Hospital Heart and Vascular Institute, Cincinnati, Ohio.
概括
这项研究证明了第一个人体使用静脉内立异 (IVL),以协助在患有严重心肌环状化 (MAC) 的患者中通过导管进行心肌替换 (TMVR). 用IVL辅助的TMVR成功治疗了严重的额头肌狭窄和吐,改善了门功能.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管外科心血管外科
- 医疗器械技术 医疗器械技术
背景情况:
- 过导管 mitra 置换 (TMVR) 面临着严重的 mitra 环状化 (MAC) 的挑战,可能导致不完全扩张.
- 血管内透症 (IVL) 已在皮肤通膜膜造膜术中表现出有前途的结果,用于缩性胸膜狭窄.
研究的目的:
- 报道人类首次使用IVL辅助跨septalTMVR使用Intrepid门在一个患有严重MAC的患者.
- 评估这种新方法的可行性和初步结果.
主要方法:
- 一名83岁的男性患有严重的MAC和耐火性心力衰竭,用48毫米的Intrepid门进行了穿越性TMVR.
- 冲击波IVL在膜植入之前通过心肌环传递,以促进扩张.
- 在手术过程中使用了脑栓塞保护.
主要成果:
- 观察到初始的植入后门框架变形和中度的 mitralia 吐 (MR).
- 扩张后成功扩大了门框架,减少了MR.
- 随访成像显示了MR的逐渐门扩张和分辨率.
结论:
- 在患有严重MAC的患者中,IVL可以增强环状合规性,并减少TMVR门架变形.
- 需要进一步的研究,以确定IVL在这个患者群体中作为TMVR的常规辅助.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


